|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Biomarin Pharmaceutical (NASDAQ: BMRN) through any online brokerage.
The latest price target for Biomarin Pharmaceutical (NASDAQ: BMRN) was reported by Morgan Stanley on April 19, 2021. The analyst firm set a price target for 82.00 expecting BMRN to rise to within 12 months (a possible 1.06% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Biomarin Pharmaceutical (NASDAQ: BMRN) is $81.14 last updated Tue Jun 22 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Biomarin Pharmaceutical.
There is no upcoming split for Biomarin Pharmaceutical.
Biomarin Pharmaceutical is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.